A TRGT tem que se ver porque é que levou a pancada, mas parece interessante por outros motivos.
A minha próxima aposta em neste sector é a CBRX que parece ter arrancado e que tem aquele padrão tipo ARNA e AFFY
Compare that to another speculative stock I think is a terrific buy right here, MannKind (MNKD):
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Os rankings são por pageviews, podes ver todos aqui: http://seekingalpha.com/leader-board/opinion-leaders O disclosure é standard, igual para todos os que escolham o mesmo.
NAVB 3.47OCT 19 '12 4 Call 2 a 0.4OCT 19 '12 4 Put 1 a 1.0Mais um teste.
In the CRL, the FDA noted the decision was focused on issues with third-party Lymphoseek contractmanufacturing, and was not related to any efficacy or safety data filed within the Lymphoseek NDA
third-party contract manufacturers
"We arealready working closely with the FDA and our third-party contract manufacturersto address all requirements to support the shortest possible NDA resubmissionand review. We remain confident that our clinical data clearly demonstrate thevalue of Lymphoseek in accurately identifying lymph nodes that most likelyharbor cancer while producing no clinically significant adverse effects